Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)
|
6 Months Ended |
Jun. 30, 2016 |
| Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities |
|
| Schedule of marketable investment securities, restricted cash and other investment securities |
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
|
June 30,
|
|
December 31,
|
|
|
|
|
2016
|
|
2015
|
|
|
|
|
(In thousands)
|
|
|
Marketable investment securities:
|
|
|
|
|
|
|
|
|
Current marketable investment securities - strategic
|
|
$
|
32,543
|
|
$
|
259,145
|
|
|
Current marketable investment securities - other
|
|
|
105,386
|
|
|
298,766
|
|
|
Total current marketable investment securities
|
|
|
137,929
|
|
|
557,911
|
|
|
Restricted marketable investment securities (1)
|
|
|
82,099
|
|
|
82,280
|
|
|
Total marketable investment securities
|
|
|
220,028
|
|
|
640,191
|
|
|
|
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents (1)
|
|
|
275
|
|
|
94
|
|
|
|
|
|
|
|
|
|
|
|
Other investment securities:
|
|
|
|
|
|
|
|
|
Investment in EchoStar preferred tracking stock - cost method
|
|
|
228,795
|
|
|
228,795
|
|
|
Investment in HSSC preferred tracking stock - cost method
|
|
|
87,409
|
|
|
87,409
|
|
|
Other investment securities - cost method
|
|
|
8,167
|
|
|
11,046
|
|
|
Total other investment securities
|
|
|
324,371
|
|
|
327,250
|
|
|
|
|
|
|
|
|
|
|
|
Total marketable investment securities, restricted cash and cash equivalents, and other investment securities
|
|
$
|
544,674
|
|
$
|
967,535
|
|
|
|
|
|
|
|
|
|
|
|
(1)
| |
Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets. |
|
| Schedule of components of available-for-sale investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2016
|
|
As of December 31, 2015
|
|
|
|
Marketable
|
|
|
|
|
|
|
|
|
|
|
Marketable
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
Unrealized
|
|
Investment
|
|
Unrealized
|
|
|
|
Securities
|
|
Gains
|
|
Losses
|
|
Net
|
|
Securities
|
|
Gains
|
|
Losses
|
|
Net
|
|
|
|
(In thousands)
|
|
|
Debt securities (including restricted):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U. S. Treasury and agency securities
|
$
|
82,290
|
|
$
|
118
|
|
$
|
—
|
|
$
|
118
|
|
$
|
82,124
|
|
$
|
2
|
|
$
|
(135)
|
|
$
|
(133)
|
|
|
Corporate securities
|
|
125,282
|
|
|
5,536
|
|
|
(4)
|
|
|
5,532
|
|
|
349,897
|
|
|
29,370
|
|
|
(480)
|
|
|
28,890
|
|
|
Other
|
|
1,184
|
|
|
68
|
|
|
(11)
|
|
|
57
|
|
|
47,847
|
|
|
73
|
|
|
(17)
|
|
|
56
|
|
|
Equity securities
|
|
11,272
|
|
|
—
|
|
|
(1,932)
|
|
|
(1,932)
|
|
|
160,323
|
|
|
68,751
|
|
|
(41)
|
|
|
68,710
|
|
|
Total
|
$
|
220,028
|
|
$
|
5,722
|
|
$
|
(1,947)
|
|
$
|
3,775
|
|
$
|
640,191
|
|
$
|
98,196
|
|
$
|
(673)
|
|
$
|
97,523
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of available-for-sale securities in continuous unrealized loss position by length of time and their fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
|
|
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
|
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
|
|
|
(In thousands)
|
|
|
Debt Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 12 months
|
|
$
|
13,174
|
|
$
|
(4)
|
|
$
|
303,194
|
|
$
|
(612)
|
|
|
12 months or more
|
|
|
127
|
|
|
(11)
|
|
|
7,512
|
|
|
(20)
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 12 months
|
|
|
6,012
|
|
|
(1,932)
|
|
|
6,133
|
|
|
(41)
|
|
|
12 months or more
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
$
|
19,313
|
|
$
|
(1,947)
|
|
$
|
316,839
|
|
$
|
(673)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of fair value measurements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
|
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
|
|
(In thousands)
|
|
|
Cash equivalents (including restricted)
|
$
|
3,260,509
|
|
$
|
2,681,628
|
|
$
|
578,881
|
|
$
|
—
|
|
$
|
920,689
|
|
$
|
82,675
|
|
$
|
838,014
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities (including restricted):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U. S. Treasury and agency securities
|
$
|
82,290
|
|
$
|
77,560
|
|
$
|
4,730
|
|
$
|
—
|
|
$
|
82,124
|
|
$
|
77,328
|
|
$
|
4,796
|
|
$
|
—
|
|
|
Corporate securities
|
|
125,282
|
|
|
—
|
|
|
119,118
|
|
|
6,164
|
|
|
349,897
|
|
|
—
|
|
|
343,733
|
|
|
6,164
|
|
|
Other
|
|
1,184
|
|
|
—
|
|
|
989
|
|
|
195
|
|
|
47,847
|
|
|
—
|
|
|
47,648
|
|
|
199
|
|
|
Equity securities
|
|
11,272
|
|
|
11,272
|
|
|
—
|
|
|
—
|
|
|
160,323
|
|
|
160,323
|
|
|
—
|
|
|
—
|
|
|
Subtotal
|
|
220,028
|
|
|
88,832
|
|
|
124,837
|
|
|
6,359
|
|
|
640,191
|
|
|
237,651
|
|
|
396,177
|
|
|
6,363
|
|
|
Derivative financial instruments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
556,828
|
|
|
—
|
|
|
556,828
|
|
|
—
|
|
|
Total
|
$
|
220,028
|
|
$
|
88,832
|
|
$
|
124,837
|
|
$
|
6,359
|
|
$
|
1,197,019
|
|
$
|
237,651
|
|
$
|
953,005
|
|
$
|
6,363
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of changes in Level 3 instruments |
|
|
|
|
|
|
|
|
|
Level 3
|
|
|
|
|
Investment
|
|
|
|
|
Securities
|
|
|
|
|
(In thousands)
|
|
|
Balance as of December 31, 2015
|
|
$
|
6,363
|
|
|
Net realized and unrealized gains (losses) included in earnings
|
|
|
—
|
|
|
Net realized and unrealized gains (losses) included in other comprehensive income (loss)
|
|
|
92
|
|
|
Purchases
|
|
|
—
|
|
|
Settlements
|
|
|
(96)
|
|
|
Issuances
|
|
|
—
|
|
|
Transfers into or out of Level 3
|
|
|
—
|
|
|
Balance as of June 30, 2016
|
|
$
|
6,359
|
|
|
|
|
|
|
|
|
| Schedule of gains and losses on sales and changes in carrying values of investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
For the Six Months
|
|
|
|
|
Ended June 30,
|
|
Ended June 30,
|
|
|
Other Income (Expense):
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
|
|
|
(In thousands)
|
|
|
Marketable investment securities - gains (losses) on sales/exchanges
|
|
$
|
29,868
|
|
$
|
34,927
|
|
$
|
108,521
|
|
$
|
99,907
|
|
|
Derivative financial instruments - net realized and/or unrealized gains (losses)
|
|
|
17,078
|
|
|
100,776
|
|
|
5,405
|
|
|
168,387
|
|
|
Marketable investment securities - other-than-temporary impairments
|
|
|
(914)
|
|
|
—
|
|
|
(914)
|
|
|
(5,567)
|
|
|
Other
|
|
|
(2,091)
|
|
|
(225)
|
|
|
(2,006)
|
|
|
(6,960)
|
|
|
Total
|
|
$
|
43,941
|
|
$
|
135,478
|
|
$
|
111,006
|
|
$
|
255,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|